Publication Detail

Citation : Horton JS, Buckley CL, Stokes AJ. (2013)
Successful TRPV1 antagonist treatment for cardiac hypertrophy and heart failure in mice.
Channels (Austin) 7(1):17-22.
Abstract : Heart failure is becoming a global epidemic. It exerts a staggering toll on quality of life, and substantial medical and economic impact. In a pre-clinical model of cardiac hypertrophy and heart failure, we were able to overcome loss of heart function by administering the TRPV1 antagonist BCTC (4-(3-Chloro-2-pyridinyl)-N-[4-(1,1-dimethylethyl)phenyl]-1-piperazinecarboxamide). The results presented here identify TRPV1 antagonists as new treatment options for cardiac hypertrophy and heart failure.
URL Link : http://www.ncbi.nlm.nih.gov/pubmed/23221478
PMID : 23221478
PMCID : PMC3589277
News
04 October 2019:
NIH Loan Repayment Applications Now Being Accepted

Applications are currently being accepted for the FY 2020 NIH Loan Repayment Program (LRP) until November 15, 2019.

For over three decades, the NI…
20 August 2019:
PMCID Training Module

An online training module has been developed with support from the RMATRIX and Ola HAWAII grants. This module, entitled PMCIDs: Tracking & Submitting …
12 April 2019:
UHCC/USC Postdoctoral Fellowships

Postdoctoral Fellowships
Multidisciplinary training in ethnic diversity and cancer disparities

Program

The University of Hawaii Cancer Center (…
View more news...


Seminars & Events
18 October 2018, 11:00am - 2:00pm:
Data Security & Privacy
06 September 2018, 11:30am - 1:00pm:
Ola HAWAII Forum - Brown Bag Session
18 April 2018, 8am:
ANNUAL BIOMEDICAL SCIENCES and HEALTH DISPARITIES SYMPOSIUM
View more seminars & events...

Supported by a grant from the National Institute on Minority Health and Health Disparities (U54MD007584), National Institutes of Health.